3 Surprising Things Your HSA Can Cover

Health Savings Accounts (HSAs) provide a triple tax advantage—tax-deductible contributions, tax-free investment growth, and tax-free withdrawals for qualified medical expenses—and balances do not expire, enabling use as a retirement savings vehicle. The piece emphasizes lesser-known eligible expenses (dental and orthodontia, vision-correction surgeries such as LASIK, and certain long-term care insurance premiums within IRS limits) and urges account holders to familiarize themselves with eligibility rules to maximize tax-advantaged healthcare and retirement funding.

Analysis

Market structure: Greater HSA adoption (driven by HDHP enrollment and tax-aware savers) reallocates household savings into tax-advantaged accounts that can be invested—this favors HSA custodians (HealthEquity HQY), asset managers that supply HSA mutual funds/ETFs, and insurers that sell HDHPs (UNH, CI). Elective-care categories (dental, LASIK) see steadier out-of-pocket demand financed by HSAs, concentrating pricing power with large provider chains and financing platforms that integrate billing and custodial services.

Risk assessment: Key tail risk is regulatory change — a Congressional push to limit the “triple tax” HSA benefit would cut growth; model a 30–50% haircut to projected custodian AUM growth if rules change within 12–24 months. Short-term (weeks) effects are minor; medium-term (6–12 months) impacts concentrate around open enrollment cycles and tax-year contribution flows; long term (3–7 years) aging demographics increase demand for LTC-funded premiums.

Trade implications: Direct plays include long custodians (HQY) and selective insurers (UNH) to capture AUM and policy distribution; use 3–9 month call spreads to express upside while limiting premium outlay. Cross-asset: modestly bullish equities vs. long-duration bonds (rising equity allocation in HSAs favors equities), and higher options volume on healthcare ETFs (XLV) as retail funnels HSA assets into ETFs.

Contrarian angles: Consensus underestimates distribution economics — custodians can monetize advisory and payments, not just float, implying 15–25% revenue CAGR potential vs. street 8–12%. Reaction is underdone for HQY and UNH but could be overdone if Congress narrows eligibility; historical parallel: 401(k) custodial market captured decade-long fee revenue after initial adoption surge. Unintended consequence: higher HSA saving may blunt near-term consumer discretionary spending by up to 1–1.5% of household nonessential outlays over 2 years.

Key Decisions for Investors

• Establish a 2–3% long position in HealthEquity (HQY) within 2–4 weeks to capture AUM growth from HSA inflows; target +20–30% return over 9–12 months, set a hard stop-loss at -12% and trim 50% on +18% gain.
• Initiate a defined-risk options trade: buy a 3–6 month HQY call spread (buy ATM, sell +15% strike) sized to 1% portfolio risk to exploit post-open-enrollment AUM acceleration while limiting premium loss.
• Overweight UnitedHealth (UNH) by 1–2% vs. XLV benchmark to gain distribution/Optum exposure to HSA-funded products; target 12-month relative outperformance of +5–8%, reduce exposure 50% if congressional HSA tax-limit legislation advances (monitor votes within next 60 days).
• Rotate 2–3% from consumer discretionary (XLY) into healthcare services (XLV) over 1–3 months anticipating reallocation of HSA capital into medical/dental/vision spend; if HSAs grow AUM >10% YoY (check quarterly filings), add another 1% to XLV.